Max Healthcare NCLT hearing on BRS Capital petition adjourned to Sept 8
Max Healthcare Institute disclosed that the NCLT Cuttack Bench adjourned a hearing involving its subsidiary Kalinga Hospital Ltd and petitioner BRS Capital Two Pte. Limited. The next hearing is scheduled for September 8, 2026. The disclosure was made under Regulation 30 of SEBI LODR regulations.
*this image is generated using AI for illustrative purposes only.
The National Company Law Tribunal (NCLT), Cuttack Bench, has adjourned the hearing on a petition filed by legal representatives of BRS Capital Two Pte. Limited. The case involves Kalinga Hospital Ltd ("KHL"), a subsidiary of Max Healthcare Institute , and the other shareholder from whom the company acquired a majority equity stake.
The matter was listed for hearing on August 19, 2026, at 11:30 am. During the proceedings, the legal representatives of BRS Capital Two sought an adjournment. The tribunal granted the request and posted the matter for further hearing on September 8, 2026.
This disclosure is made in continuation of an earlier intimation dated August 7, 2026, regarding petitions, including interlocutory petitions, filed before the NCLT. The development is reported under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Case Details
| Particulars | Details |
|---|---|
| Forum | National Company Law Tribunal, Cuttack Bench |
| Petitioner | Legal representatives of BRS Capital Two Pte. Limited |
| Respondents | Kalinga Hospital Ltd, Max Healthcare Institute, other shareholder |
| Previous Hearing Date | August 19, 2026 |
| Next Hearing Date | September 8, 2026 |
| Reason for Adjournment | Requested by legal representatives of BRS Capital Two |
The company confirmed that there is no change in the status regarding litigation against key management personnel or promoters. Additionally, no settlement has been reached in these proceedings as of the date of this disclosure.
Historical Stock Returns for Max Healthcare Institute
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.72% | -4.13% | -9.56% | -8.22% | -17.71% | +190.54% |
What specific legal arguments or evidence is BRS Capital Two likely to present at the September 8 hearing that necessitated the adjournment?
How might a prolonged litigation process regarding the equity stake acquisition impact Max Healthcare's integration strategy for Kalinga Hospital Ltd?
Could this ongoing dispute signal potential regulatory scrutiny or compliance issues under SEBI regulations for Max Healthcare's corporate governance practices?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
